Detalhe da pesquisa
1.
A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma.
Cell
; 177(3): 572-586.e22, 2019 04 18.
Artigo
Inglês
| MEDLINE | ID: mdl-30955884
2.
Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancer.
Gut
; 72(8): 1523-1533, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-36792355
3.
Emerging Prognostic and Predictive Factors in Pancreatic Cancer.
Mod Pathol
; 36(11): 100328, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37714333
4.
Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer.
Immunity
; 39(6): 1095-107, 2013 Dec 12.
Artigo
Inglês
| MEDLINE | ID: mdl-24290911
5.
Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features.
Br J Cancer
; 121(1): 5-14, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31110329
6.
Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system.
Histopathology
; 73(1): 137-146, 2018 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-29495092
7.
High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy.
Mol Carcinog
; 56(9): 2146-2157, 2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28467612
8.
MicroRNA dysregulation in the tumor microenvironment influences the phenotype of pancreatic cancer.
Mod Pathol
; 30(8): 1116-1125, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28548126
9.
A severe case of visceral leishmaniasis and liposomal amphotericin B treatment failure in an immunosuppressed patient 15 years after exposure.
BMC Infect Dis
; 17(1): 81, 2017 01 17.
Artigo
Inglês
| MEDLINE | ID: mdl-28095796
10.
Glucagon-like-peptide-1 receptor expression in normal and diseased human thyroid and pancreas.
Mod Pathol
; 28(3): 391-402, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25216224
11.
Loss of tapasin correlates with diminished CD8(+) T-cell immunity and prognosis in colorectal cancer.
J Transl Med
; 13: 279, 2015 Aug 27.
Artigo
Inglês
| MEDLINE | ID: mdl-26310568
12.
Tumour border configuration in colorectal cancer: proposal for an alternative scoring system based on the percentage of infiltrating margin.
Histopathology
; 67(4): 464-73, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25648412
13.
Tyrosine kinase receptor B (TrkB) expression in colorectal cancers highlights anoikis resistance as a survival mechanism of tumour budding cells.
Histopathology
; 66(5): 715-25, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25382057
14.
Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study.
BMC Cancer
; 15: 160, 2015 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-25884643
15.
Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
Int J Cancer
; 134(10): 2342-51, 2014 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24166180
16.
The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome.
Histopathology
; 64(4): 577-84, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-24111856
17.
Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer.
Mod Pathol
; 26(2): 295-301, 2013 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23018875
18.
Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC).
J Transl Med
; 11: 311, 2013 Dec 14.
Artigo
Inglês
| MEDLINE | ID: mdl-24330423
19.
Determining HER2 Status by Artificial Intelligence: An Investigation of Primary, Metastatic, and HER2 Low Breast Tumors.
Diagnostics (Basel)
; 13(1)2023 Jan 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36611460
20.
Immune escape of colorectal tumours via local LRH-1/Cyp11b1-mediated synthesis of immunosuppressive glucocorticoids.
Mol Oncol
; 17(8): 1545-1566, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36861295